西蒙顾和：2024年欧洲生物制药首药成功上市与商业化七大秘诀-了解产品价值驱动因素与发掘之道（英文版）

Transitioning from an R&D-focused biopharma company to a commercially viable operation is already a challenging endeavor, and the prospect of having to master complex European launch requirements while also steering US business makes this shift even more daunting. To help companies assess the general viability of such ventures, this Simon-Kucher whitepaper identifies common characteristics among independent operations and carves out key managerial implications to enable business lead